November 29, 2011 -- Jiangsu Sihuan Bioengineering is suing Vitapharm Technology Co. of Australia. Last year, Sihuan bought China rights to Vitapharm’s sublingual drug delivery technology, but Sihuan now claims Vitapharm did not have an effective patent for the technology. Sihuan is asking a Beijing court to set aside the transaction. More details....
Stock Symbol: (SHE: 000518)
